↓ Skip to main content

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
61 Mendeley